News and Announcements
Rapid, Award Winning Diagnostic Tests to be Presented at MEDICA
- Published October 27, 2015 5:59PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd October 2015, News Medical
A Bloxham-based company focused on improving the usability, safety and accuracy of rapid diagnostic tests will present its fully integrated AtomoRapid™ product range at MEDICA 2015, the world’s largest medical trade fair.
Atomo Diagnostics will showcase its award-winning AtomoRapid HIV and AtomoRapid Malaria rapid diagnostic tests in Hall 1 Stand E06.
The company’s AtomoRapid platform replaces costly and time-consuming blood testing procedures by incorporating functionality into one easy-to-use device. The all-in-one platform removes the need for multiple test components and, by simplifying user steps, helps to address errors common with standard rapid diagnostic tests.
AtomoRapid HIV has established itself as the ‘best in class’ solution for professional use HIV screening and won both the In Vitro Diagnostic and ‘Best in Show’ categories at the Medical Design Excellence Awards 2014.
To read the full article, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
